Global Antihypertensive Market Research Report 2023(Status and Outlook)

Global Antihypertensive Market Research Report 2023(Status and Outlook)



Report Overview

Increase in blood pressure is measured in terms of systolic and diastolic blood pressure exerted by blood on the wall of artery and hence it is also termed as arterial hypertension. Reduction in blood pressure minimizes the risk of heart failure, ischaemic heart diseases, dementia and mortality due to hypertension.

The Global Antihypertensive Market Size was estimated at USD 19250.00 million in 2022 and is projected to reach USD 22264.40 million by 2029, exhibiting a CAGR of 2.10% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Antihypertensive market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Antihypertensive Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Antihypertensive market in any manner.

Global Antihypertensive Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Pfizer

Norvatis

Merck & Co.

Sanofi

AstraZeneca

GSK

Daiichi-Sankyo

Boehringer-Ingelheim

Bayer

Johnson & Johnson

Bristol-Myers Squibb

Tekeda

Ranbaxy Laboratories

Shihuida Pharm

Second Pharmaceutical

Lupin Limited.

Yangtze River Pharmaceutical

Hengrui Medicine

Qilu Pharmaceutical

HUALON

Dawnrays

HISUN Pharmceutical

Market Segmentation (by Type)

Diuretics

Angiotensin Converting Enzyme (ACE) Inhibitors

Angiotensin Receptor Blockers (ARBs)

Calcium Channel Blockers

Beta Blockers

Alpha Blockers

Vasodilators & Renin Inhibitors

Market Segmentation (by Application)

Small Business (10-49)

Medium-sized Business (50-249)

Large Business (250+)

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Antihypertensive Market

Overview of the regional outlook of the Antihypertensive Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Antihypertensive
1.2 Key Market Segments
1.2.1 Antihypertensive Segment by Type
1.2.2 Antihypertensive Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Antihypertensive Market Overview
2.1 Global Market Overview
2.1.1 Global Antihypertensive Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Antihypertensive Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Antihypertensive Market Competitive Landscape
3.1 Global Antihypertensive Sales by Manufacturers (2018-2023)
3.2 Global Antihypertensive Revenue Market Share by Manufacturers (2018-2023)
3.3 Antihypertensive Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Antihypertensive Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Antihypertensive Sales Sites, Area Served, Product Type
3.6 Antihypertensive Market Competitive Situation and Trends
3.6.1 Antihypertensive Market Concentration Rate
3.6.2 Global 5 and 10 Largest Antihypertensive Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Antihypertensive Industry Chain Analysis
4.1 Antihypertensive Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Antihypertensive Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Antihypertensive Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Antihypertensive Sales Market Share by Type (2018-2023)
6.3 Global Antihypertensive Market Size Market Share by Type (2018-2023)
6.4 Global Antihypertensive Price by Type (2018-2023)
7 Antihypertensive Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Antihypertensive Market Sales by Application (2018-2023)
7.3 Global Antihypertensive Market Size (M USD) by Application (2018-2023)
7.4 Global Antihypertensive Sales Growth Rate by Application (2018-2023)
8 Antihypertensive Market Segmentation by Region
8.1 Global Antihypertensive Sales by Region
8.1.1 Global Antihypertensive Sales by Region
8.1.2 Global Antihypertensive Sales Market Share by Region
8.2 North America
8.2.1 North America Antihypertensive Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Antihypertensive Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Antihypertensive Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Antihypertensive Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Antihypertensive Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Pfizer
9.1.1 Pfizer Antihypertensive Basic Information
9.1.2 Pfizer Antihypertensive Product Overview
9.1.3 Pfizer Antihypertensive Product Market Performance
9.1.4 Pfizer Business Overview
9.1.5 Pfizer Antihypertensive SWOT Analysis
9.1.6 Pfizer Recent Developments
9.2 Norvatis
9.2.1 Norvatis Antihypertensive Basic Information
9.2.2 Norvatis Antihypertensive Product Overview
9.2.3 Norvatis Antihypertensive Product Market Performance
9.2.4 Norvatis Business Overview
9.2.5 Norvatis Antihypertensive SWOT Analysis
9.2.6 Norvatis Recent Developments
9.3 Merck andamp; Co.
9.3.1 Merck andamp; Co. Antihypertensive Basic Information
9.3.2 Merck andamp; Co. Antihypertensive Product Overview
9.3.3 Merck andamp; Co. Antihypertensive Product Market Performance
9.3.4 Merck andamp; Co. Business Overview
9.3.5 Merck andamp; Co. Antihypertensive SWOT Analysis
9.3.6 Merck andamp; Co. Recent Developments
9.4 Sanofi
9.4.1 Sanofi Antihypertensive Basic Information
9.4.2 Sanofi Antihypertensive Product Overview
9.4.3 Sanofi Antihypertensive Product Market Performance
9.4.4 Sanofi Business Overview
9.4.5 Sanofi Antihypertensive SWOT Analysis
9.4.6 Sanofi Recent Developments
9.5 AstraZeneca
9.5.1 AstraZeneca Antihypertensive Basic Information
9.5.2 AstraZeneca Antihypertensive Product Overview
9.5.3 AstraZeneca Antihypertensive Product Market Performance
9.5.4 AstraZeneca Business Overview
9.5.5 AstraZeneca Antihypertensive SWOT Analysis
9.5.6 AstraZeneca Recent Developments
9.6 GSK
9.6.1 GSK Antihypertensive Basic Information
9.6.2 GSK Antihypertensive Product Overview
9.6.3 GSK Antihypertensive Product Market Performance
9.6.4 GSK Business Overview
9.6.5 GSK Recent Developments
9.7 Daiichi-Sankyo
9.7.1 Daiichi-Sankyo Antihypertensive Basic Information
9.7.2 Daiichi-Sankyo Antihypertensive Product Overview
9.7.3 Daiichi-Sankyo Antihypertensive Product Market Performance
9.7.4 Daiichi-Sankyo Business Overview
9.7.5 Daiichi-Sankyo Recent Developments
9.8 Boehringer-Ingelheim
9.8.1 Boehringer-Ingelheim Antihypertensive Basic Information
9.8.2 Boehringer-Ingelheim Antihypertensive Product Overview
9.8.3 Boehringer-Ingelheim Antihypertensive Product Market Performance
9.8.4 Boehringer-Ingelheim Business Overview
9.8.5 Boehringer-Ingelheim Recent Developments
9.9 Bayer
9.9.1 Bayer Antihypertensive Basic Information
9.9.2 Bayer Antihypertensive Product Overview
9.9.3 Bayer Antihypertensive Product Market Performance
9.9.4 Bayer Business Overview
9.9.5 Bayer Recent Developments
9.10 Johnson andamp; Johnson
9.10.1 Johnson andamp; Johnson Antihypertensive Basic Information
9.10.2 Johnson andamp; Johnson Antihypertensive Product Overview
9.10.3 Johnson andamp; Johnson Antihypertensive Product Market Performance
9.10.4 Johnson andamp; Johnson Business Overview
9.10.5 Johnson andamp; Johnson Recent Developments
9.11 Bristol-Myers Squibb
9.11.1 Bristol-Myers Squibb Antihypertensive Basic Information
9.11.2 Bristol-Myers Squibb Antihypertensive Product Overview
9.11.3 Bristol-Myers Squibb Antihypertensive Product Market Performance
9.11.4 Bristol-Myers Squibb Business Overview
9.11.5 Bristol-Myers Squibb Recent Developments
9.12 Tekeda
9.12.1 Tekeda Antihypertensive Basic Information
9.12.2 Tekeda Antihypertensive Product Overview
9.12.3 Tekeda Antihypertensive Product Market Performance
9.12.4 Tekeda Business Overview
9.12.5 Tekeda Recent Developments
9.13 Ranbaxy Laboratories
9.13.1 Ranbaxy Laboratories Antihypertensive Basic Information
9.13.2 Ranbaxy Laboratories Antihypertensive Product Overview
9.13.3 Ranbaxy Laboratories Antihypertensive Product Market Performance
9.13.4 Ranbaxy Laboratories Business Overview
9.13.5 Ranbaxy Laboratories Recent Developments
9.14 Shihuida Pharm
9.14.1 Shihuida Pharm Antihypertensive Basic Information
9.14.2 Shihuida Pharm Antihypertensive Product Overview
9.14.3 Shihuida Pharm Antihypertensive Product Market Performance
9.14.4 Shihuida Pharm Business Overview
9.14.5 Shihuida Pharm Recent Developments
9.15 Second Pharmaceutical
9.15.1 Second Pharmaceutical Antihypertensive Basic Information
9.15.2 Second Pharmaceutical Antihypertensive Product Overview
9.15.3 Second Pharmaceutical Antihypertensive Product Market Performance
9.15.4 Second Pharmaceutical Business Overview
9.15.5 Second Pharmaceutical Recent Developments
9.16 Lupin Limited.
9.16.1 Lupin Limited. Antihypertensive Basic Information
9.16.2 Lupin Limited. Antihypertensive Product Overview
9.16.3 Lupin Limited. Antihypertensive Product Market Performance
9.16.4 Lupin Limited. Business Overview
9.16.5 Lupin Limited. Recent Developments
9.17 Yangtze River Pharmaceutical
9.17.1 Yangtze River Pharmaceutical Antihypertensive Basic Information
9.17.2 Yangtze River Pharmaceutical Antihypertensive Product Overview
9.17.3 Yangtze River Pharmaceutical Antihypertensive Product Market Performance
9.17.4 Yangtze River Pharmaceutical Business Overview
9.17.5 Yangtze River Pharmaceutical Recent Developments
9.18 Hengrui Medicine
9.18.1 Hengrui Medicine Antihypertensive Basic Information
9.18.2 Hengrui Medicine Antihypertensive Product Overview
9.18.3 Hengrui Medicine Antihypertensive Product Market Performance
9.18.4 Hengrui Medicine Business Overview
9.18.5 Hengrui Medicine Recent Developments
9.19 Qilu Pharmaceutical
9.19.1 Qilu Pharmaceutical Antihypertensive Basic Information
9.19.2 Qilu Pharmaceutical Antihypertensive Product Overview
9.19.3 Qilu Pharmaceutical Antihypertensive Product Market Performance
9.19.4 Qilu Pharmaceutical Business Overview
9.19.5 Qilu Pharmaceutical Recent Developments
9.20 HUALON
9.20.1 HUALON Antihypertensive Basic Information
9.20.2 HUALON Antihypertensive Product Overview
9.20.3 HUALON Antihypertensive Product Market Performance
9.20.4 HUALON Business Overview
9.20.5 HUALON Recent Developments
9.21 Dawnrays
9.21.1 Dawnrays Antihypertensive Basic Information
9.21.2 Dawnrays Antihypertensive Product Overview
9.21.3 Dawnrays Antihypertensive Product Market Performance
9.21.4 Dawnrays Business Overview
9.21.5 Dawnrays Recent Developments
9.22 HISUN Pharmceutical
9.22.1 HISUN Pharmceutical Antihypertensive Basic Information
9.22.2 HISUN Pharmceutical Antihypertensive Product Overview
9.22.3 HISUN Pharmceutical Antihypertensive Product Market Performance
9.22.4 HISUN Pharmceutical Business Overview
9.22.5 HISUN Pharmceutical Recent Developments
10 Antihypertensive Market Forecast by Region
10.1 Global Antihypertensive Market Size Forecast
10.2 Global Antihypertensive Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Antihypertensive Market Size Forecast by Country
10.2.3 Asia Pacific Antihypertensive Market Size Forecast by Region
10.2.4 South America Antihypertensive Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Antihypertensive by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Antihypertensive Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Antihypertensive by Type (2024-2029)
11.1.2 Global Antihypertensive Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Antihypertensive by Type (2024-2029)
11.2 Global Antihypertensive Market Forecast by Application (2024-2029)
11.2.1 Global Antihypertensive Sales (K MT) Forecast by Application
11.2.2 Global Antihypertensive Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings